Journal of Clinical and Experimental Toxicology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518-081136

Perspective - Journal of Clinical and Experimental Toxicology (2023) Volume 7, Issue 4

The Role of Genotoxicity in Carcinogenesis: A Critical Review of the Latest Research

Karen Schuch *

Department of Ecology and Evolution, Federal University of Santa Maria, Brazil

*Corresponding Author:
Karen Schuch
Department of Ecology and Evolution, Federal University of Santa Maria, Brazil
E-mail: schuch.k@ufsm.br

Received: 04-Aug -2023, Manuscript No. AACETY-23-109171; Editor assigned: 05-Aug-2023, PreQC No. AACETY-23-109171 (PQ); Reviewed:19-Aug-2023, QC No. AACETY-23-109171; Revised:23 -Aug-2023, Manuscript No. AACETY-23-109171 (R); Published:30-Aug-2023, DOI:10.35841/2630-4570-7.4.153

Citation: Schuch K. The role of genotoxicity in carcinogenesis: A critical review of the latest research. J Clin Exp Tox. 2023;7(4):153

Visit for more related articles at Journal of Clinical and Experimental Toxicology

Introduction

Carcinogenesis, the process by which normal cells transform into cancerous cells, is a complex and multifactorial phenomenon. Over the years, extensive research has focused on understanding the role of genotoxicity in driving this transformation. Genotoxic agents have the capacity to damage DNA, and if left unrepaired, these damages can lead to mutations, genomic instability, and ultimately cancer. This mini-review critically examines the latest research on the pivotal role of genotoxicity in carcinogenesis [1].

Genotoxic agents encompass a wide range of chemicals, physical agents, and biological factors that induce DNA damage. These agents can act through various mechanisms, including direct DNA binding, the generation of reactive oxygen species, and interference with DNA repair mechanisms. Notably, mutagenic substances such as certain chemicals and radiation are well-established as potent genotoxic agents [2].

Cells have evolved complex DNA repair pathways to counteract genotoxic damage and maintain genomic stability. In normal conditions, these repair mechanisms effectively remove the majority of DNA lesions, safeguarding against cancer development. However, in cases of chronic exposure to genotoxic agents or genetic predisposition, the efficiency of DNA repair pathways may be compromised, leading to the accumulation of mutations and the initiation of carcinogenesis [3].

Recent research has highlighted the interplay between genotoxicity and oncogenes, which are genes that have the potential to cause cancer. Genotoxic damage can directly target oncogenes, activating or inactivating them through mutations. Dysregulation of oncogenes can then promote uncontrolled cell proliferation and tumorigenesis. Conversely, genotoxicity can also disrupt tumor suppressor genes, which normally act as a defense against cancer by inhibiting cell growth or inducing cell death [4].

Environmental factors play a crucial role in genotoxicity-associated carcinogenesis. Chemical pollutants, occupational hazards, lifestyle choices, and dietary factors can expose individuals to genotoxic agents, thereby increasing their cancer risk. Understanding the link between environmental exposures and genotoxicity is essential for implementing preventive measures and promoting public health [5].

conclusion

The latest research indicates that genotoxicity plays a central role in carcinogenesis by initiating DNA damage, altering oncogenes and tumor suppressor genes, driving genomic instability, and contributing to tumor evolution. This critical review underscores the significance of genotoxicity in cancer development and emphasizes the need for continued research to unravel its complexities. Identifying new targets for therapeutic interventions and implementing strategies to mitigate environmental genotoxic exposures are crucial steps toward reducing the burden of cancer and improving patient outcomes.

References

  1. Lison D, De Boeck M, Verougstraete V, et al. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup Environ Med. 2001;58(10):619-25.

    2. Indexed at, Google Scholar, Cross Ref

  2. Hang B, Wang P, Zhao Y, et al. Thirdhand smoke: Genotoxicity and carcinogenic potential. Chronic Dis. Transl. Med. 2020;6(01):27-34.

    3. Indexed at, Google Scholar, Cross Ref

  3. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen?. Endocr Rev. 2000;21(1):40-54.

    4. Indexed at, Google Scholar, Cross Ref

  4. Brambilla G, Martelli A. Genotoxic and carcinogenic risk to humans of drug–nitrite interaction products. Mutat Res Rev Mutat Res. 2007;635(1):17-52.

    5. Indexed at, Google Scholar, Cross Ref

  5. Brambilla G, Mattioli F, Martelli A. Genotoxic and carcinogenic effects of antipsychotics and antidepressants. Toxicology. 2009;261(3):77-88.

    6. Indexed at, Google Scholar, Cross Ref

Get the App